» Articles » PMID: 1409719

Brain-derived Neurotrophic Factor and Neurotrophin 3 MRNAs in the Peripheral Target Fields of Developing Inner Ear Ganglia

Overview
Specialty Science
Date 1992 Oct 15
PMID 1409719
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

In situ hybridization was used to study the site and timing of the expression of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 5 (NT-5) mRNAs in the developing inner ear of the rat. In the sensory epithelia, the levels of NGF and NT-5 mRNAs were below the detection limit. NT-3 and BDNF mRNAs were expressed in the otic vesicle in overlapping but also in distinct regions. Later in development, NT-3 transcripts were localized to the differentiating sensory and supporting cells of the auditory organ and vestibular maculae. In these sensory epithelia, the intensity of NT-3 mRNA expression decreased in parallel with maturation. The expression of BDNF mRNA was restricted to the sensory cells of both the auditory and vestibular organs, including ampullary cristae. In bioassays, BDNF and NT-3, but not NGF, at physiological concentrations induced neurite outgrowth from the statoacoustic ganglion explants. These results demonstrate that NT-3 and BDNF, rather than NGF and NT-5, are the primary neurotrophins present in the target fields of the cochlear and vestibular neurons. Expression of NT-3 and BDNF mRNAs in the otic vesicle before and during the ingrowth of neurites from the statoacoustic ganglion suggests that NT-3 or BDNF or both may serve as chemoattractants for the early nerve fibers. The results also suggest that these neurotrophins have a role in later development of the cochlear and vestibular neurons.

Citing Articles

Function of Brain-Derived Neurotrophic Factor in the Vestibular-Cochlear System.

Zhang B, Chen S, Teng X, Han Q, Wu T, Yang Z Neurochem Res. 2024; 50(1):59.

PMID: 39673652 DOI: 10.1007/s11064-024-04314-6.


Oral Administration of TrkB Agonist, 7, 8-Dihydroxyflavone Regenerates Hair Cells and Restores Function after Gentamicin-Induced Vestibular Injury in Guinea Pig.

Kinoshita M, Fujimoto C, Iwasaki S, Kondo K, Yamasoba T Pharmaceutics. 2023; 15(2).

PMID: 36839815 PMC: 9966733. DOI: 10.3390/pharmaceutics15020493.


Extracellular Vesicles in Inner Ear Therapies-Pathophysiological, Manufacturing, and Clinical Considerations.

Warnecke A, Staecker H, Rohde E, Gimona M, Giesemann A, Szczepek A J Clin Med. 2022; 11(24).

PMID: 36556073 PMC: 9788356. DOI: 10.3390/jcm11247455.


Therapeutic Application of Mesenchymal Stem Cells for Cochlear Regeneration.

Maharajan N, Cho G, Jang C In Vivo. 2021; 35(1):13-22.

PMID: 33402445 PMC: 7880755. DOI: 10.21873/invivo.12227.


Effects of Neurotrophin-3 on Intrinsic Neuronal Properties at a Central Auditory Structure.

Takahashi M, Sanchez J Neurosci Insights. 2020; 15:2633105520980442.

PMID: 33354669 PMC: 7734498. DOI: 10.1177/2633105520980442.


References
1.
Hohn A, Leibrock J, Bailey K, Barde Y . Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature. 1990; 344(6264):339-41. DOI: 10.1038/344339a0. View

2.
Lenoir M, Shnerson A, Pujol R . Cochlear receptor development in the rat with emphasis on synaptogenesis. Anat Embryol (Berl). 1980; 160(3):253-62. DOI: 10.1007/BF00305106. View

3.
Otten U, Ehrhard P, Peck R . Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci U S A. 1989; 86(24):10059-63. PMC: 298643. DOI: 10.1073/pnas.86.24.10059. View

4.
Represa J, Bernd P . Nerve growth factor and serum differentially regulate development of the embryonic otic vesicle and cochleovestibular ganglion in vitro. Dev Biol. 1989; 134(1):21-9. DOI: 10.1016/0012-1606(89)90074-2. View

5.
Raivich G, Zimmermann A, Sutter A . Nerve growth factor (NGF) receptor expression in chicken cranial development. J Comp Neurol. 1987; 256(2):229-45. DOI: 10.1002/cne.902560204. View